Trazodone in Major Affective Disorders

In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants a...

Full description

Saved in:
Bibliographic Details
Published inPsychopathology Vol. 17; no. Suppl 2; pp. 15 - 23
Main Author Feighner, John P.
Format Journal Article
LanguageEnglish
Published Basel, Switzerland 01.01.1984
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants and bridged tricyclic antidepressants are undesirable and medically contraindicated, trazodone should be one of the drugs of choice in major depressive disorders.
AbstractList In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants and bridged tricyclic antidepressants are undesirable and medically contraindicated, trazodone should be one of the drugs of choice in major depressive disorders.
Author Feighner, John P.
Author_xml – sequence: 1
  givenname: John P.
  surname: Feighner
  fullname: Feighner, John P.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6425917$$D View this record in MEDLINE/PubMed
BookMark eNptkM1Lw0AQxVet1LZ68K4QEAQP0dnP7B5L_YSKBSt4C5vNrqTaJuxWQf96VxJy8jTMvB_vMW-MBpt6YxE6xnCJMVdXAEAkAyl30JhSLIFnCotdNMKM0BQofd2LQjxzKiXLBmgEhLOUKUEO0DiEFQCOixiioWCEK5yN0PnS65-6jEFJtUke9ar2ydQ5a7bVl02uq1D70vpwiPad_gj2qJsT9HJ7s5zdp_Onu4fZdJ4aItU2dU7LQhaWuowpx50yRBe8VMAKAApcgs6McsYIhqUUHIzSpADhJAXCHKYTdNH6Gl-H4K3LG1-ttf_OMeR_JeR9CZE9bdnms1jbsie736J-1urv2r9Z3-uL50XrkDeli9TJv1QX8gsjfWeX
ContentType Journal Article
Copyright 1984 S. Karger AG, Basel
Copyright_xml – notice: 1984 S. Karger AG, Basel
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1159/000284088
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISBN 3318057916
9783318057911
EISSN 1423-033X
EndPage 23
ExternalDocumentID 10_1159_000284088
6425917
284088
Genre Comparative Study
Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.GJ
0-V
0R~
0~5
0~B
123
29P
30W
329
34G
39C
3O.
3V.
4.4
53G
5RE
7X7
88E
88I
8AF
8AO
8FI
8FJ
8UI
AALGM
AAYIC
ABDBF
ABIVO
ABJNI
ABPAZ
ABUWG
ACGFS
ACGOD
ACHQT
ACPRK
ACPSR
ADAGL
AENEX
AEYAO
AFJJK
AFKRA
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ARALO
AZPMC
AZQEC
BENPR
BGRYB
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DU5
DWQXO
E0A
EBS
EJD
F5P
FB.
FYUFA
GNUQQ
HCIFZ
HMCUK
HZ~
IY7
M0O
M1P
M2M
M2P
N9A
O1H
O9-
OVD
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
RIG
RKO
RXVBD
S0X
TEORI
UAP
UJ6
UKHRP
UKR
YNT
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c289t-ffa8b8be3f749f5f9c2ab5d904b0030580a7c9fcc64188650c9a2b06f83024f13
ISBN 3805538847
9783805538848
ISSN 0254-4962
IngestDate Wed Sep 18 12:56:04 EDT 2024
Sat Sep 28 08:48:27 EDT 2024
Thu Sep 05 17:59:19 EDT 2024
Thu Aug 29 12:04:38 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue Suppl 2
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c289t-ffa8b8be3f749f5f9c2ab5d904b0030580a7c9fcc64188650c9a2b06f83024f13
PMID 6425917
PageCount 9
ParticipantIDs pubmed_primary_6425917
karger_primary_284088
crossref_primary_10_1159_000284088
PublicationCentury 1900
PublicationDate 1984-01-01
PublicationDateYYYYMMDD 1984-01-01
PublicationDate_xml – month: 01
  year: 1984
  text: 1984-01-01
  day: 01
PublicationDecade 1980
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
PublicationTitle Psychopathology
PublicationTitleAlternate Psychopathology
PublicationYear 1984
SSID ssj0014966
Score 1.2928927
Snippet In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective...
SourceID crossref
pubmed
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 15
SubjectTerms Adolescent
Adult
Aged
Clinical Trials as Topic
Depressive Disorder - drug therapy
Depressive Disorder - psychology
Double-Blind Method
Female
Humans
Imipramine - adverse effects
Imipramine - therapeutic use
Long-Term Care
Male
Middle Aged
Piperazines - therapeutic use
Psychiatric Status Rating Scales
The Role of Trazodone in Antidepression Therapy: Safety and Clinical Efficacy
Trazodone - adverse effects
Trazodone - therapeutic use
Title Trazodone in Major Affective Disorders
URI https://karger.com/doi/10.1159/000284088
https://www.ncbi.nlm.nih.gov/pubmed/6425917
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA86P9iL-LHhdEoR8WVUuy5tk8dNHWMwGbjB3ko-GlDZGLO-7K_32mTZhwrqSymXkKT3a693l7sLQtchiaSkirk8ksTFIsEu51y4LOQJC6mfKJG5BnpPYWeIu6NgtCzwmGeXpPxWzL_NK_kPqkADXLMs2T8gawcFAtwDvnAFhOH6O4xnbA5mpS78MWavWUBkHp-RhQNJU1fzfVX_1PIuO4Z4zZ3ezhykJvWla1K-pM6NI3jFFaAlBlh7LqYb4i2q5QeE1vwVOaVTKL-Kz4DqeEP4aXn6uL0VNk7HOR_BYgmoTrjcKFVtWrbRjg-fPcibnWbrodW2uzqwtHzveLFMU-kJZr2zcxbRnhlmTVPYfcsC42cbyn-uBAwO0YHR3p2mhuIIbSWTY7TfM_EJJ-jGIuK8TJwcEcci4lhESmjYfhzcd1xzEoUrwCBNXaUY4YQnDRVhqgJFhc94IKmHtRFGPBYJqoQIcZ0QUHoFZT73QpVVV8Oq3iijwgTmPkVOyATnDNQ-Tih0lgT7SikhPZ5EClZUQVeLp46nuuBInBtqAY0tkyqopPlhuyzo1Q16_7mvm-KphLHLmnu22bD67KeGc1RcvmhVVEhnH8kFaGEpvzTgfgKE-S9L
link.rule.ids 315,783,787,27936,27937
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trazodone+in+major+affective+disorders&rft.jtitle=Psychopathology&rft.au=Feighner%2C+J+P&rft.date=1984-01-01&rft.issn=0254-4962&rft.volume=17+Suppl+2&rft.spage=15&rft_id=info:doi/10.1159%2F000284088&rft_id=info%3Apmid%2F6425917&rft.externalDocID=6425917
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0254-4962&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0254-4962&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0254-4962&client=summon